Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank: Guidance for Responsible Parties, Submitters of Certain Applications and Submissions to FDA, and FDA Staff
Information
Type
Guidance
Regulated products
Biologics, Drugs, Medical Devices
Topics
Good Clinical Practice (GCP)
Published
August 14, 2020
Last updated
August 14, 2020
Description
This document provides guidance on civil money penalties related to ClinicalTrials.gov data bank for responsible parties, submitters, and FDA staff.
Tags
Organization
Country / Region
United States
License
Other (Public Domain)